28 pending office actions • 12 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19325478 | SEMANTICALLY GENERATED VIDEO METHOD AND SYSTEM | Revealit Corporation | KY, KEVIN | 2671 | Final Rejection | Sep 10, 2025 |
| 19325482 | Semantically Interpreted Video Method, System, and Apparatus | Revealit Corporation | KY, KEVIN | 2671 | Final Rejection | Sep 10, 2025 |
| 19224794 | NEURAL NETWORK TRAINING FOR VIDEO GENERATION | Revealit Corporation | KY, KEVIN | 2671 | Final Rejection | May 31, 2025 |
| 18904649 | METHOD OF COLLECTING CONSUMER FEEDBACK IN THE METAVERSE | First Insight, Inc. | PUJOLS-CRUZ, MARJORIE | 3624 | Non-Final OA | Oct 02, 2024 |
| 18883446 | RESILIENT EXPANDABLE STERILIZABLE PACKAGING FOR INDIVIDUAL ITEMS | Roesler Ip GmbH | BUI, LUAN KIM | 3736 | Non-Final OA | Sep 12, 2024 |
| 18838315 | LIQUID CRYSTAL ELASTOMER WITH INTEGRATED SOFT THERMOELECTRICS FOR SHAPE MEMORY ACTUATION AND ENERGY HARVESTING | Carnegie Mellon University | KANG, TAE-SIK | 1728 | Non-Final OA | Aug 14, 2024 |
| 18672909 | IMPORTATION AND TRANSFORMATION TOOL FOR UTILIZING COMPUTER-AIDED DESIGN FILES IN A WEB BROWSER OR CUSTOMIZED CLIENT INTERFACE | Unknown | NGUYEN, ANH TUAN V | 2619 | Non-Final OA | May 23, 2024 |
| 18662467 | VEHICLE WASH SYSTEM | Unknown | ADHLAKHA, RITA P | 1711 | Non-Final OA | May 13, 2024 |
| 18632379 | HUMANIZED ANTI-CD45 ANTIBODIES | Actinium Pharmaceuticals, Inc. | CHASE, CAROL ANN | 1646 | Final Rejection | Apr 11, 2024 |
| 18406715 | LUGGAGE COVER | Unknown | WEAVER, SUE A | 3733 | Non-Final OA | Jan 08, 2024 |
| 18514319 | RELATIONAL BIOMARKERS THAT DISTINGUISH DISEASES AND DISORDERS FROM CONTROLS AND USES THEREOF TO PREDICT PATHOPHYSIOLOGICAL OUTCOMES | Signature Diagnostics Inc. | VANNI, GEORGE STEVEN | 1686 | Final Rejection | Nov 20, 2023 |
| 18382028 | ANCHORING PLATE | Spinnanker GmbH | HIJAZ, OMAR F | 3635 | Final Rejection | Oct 19, 2023 |
| 18374875 | METHOD FOR IDENTIFYING AND INITIATING REVERSIBLE SUBROGATION CLAIMS | Second Look, Inc. | KANAAN, TONY P | 3696 | Non-Final OA | Sep 29, 2023 |
| 18036815 | SECRETOME FRACTIONS AND USES THEREOF | Noveome Biotherapeutics, Inc. | KNIGHT, TERESA E | 1634 | Non-Final OA | May 12, 2023 |
| 18025849 | TROPHOBLAST GLYCOPROTEIN RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | Actinium Pharmaceuticals, Inc. | CRAIG, KAILA ANGELIQUE | 1618 | Non-Final OA | Mar 10, 2023 |
| 18146149 | HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | Actinium Pharmaceuticals, Inc. | LOCKARD, JON MCCLELLAND | 1647 | Non-Final OA | Dec 23, 2022 |
| 17662474 | Bioreactors and Bioreactor Facilities that Include a Plurality of Bioreactor Tiles | Candice Hovell | ABEL, LENORA A | 1799 | Final Rejection | May 09, 2022 |
| 17726296 | COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER | Actinium Pharmaceuticals, Inc. | ROGERS, JAMES WILLIAM | 1618 | Final Rejection | Apr 21, 2022 |
| 17702648 | COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER | Actinium Pharmaceuticals, Inc. | CUNNINGCHEN, KATHLEEN MARY | 1646 | Non-Final OA | Mar 23, 2022 |
| 17532919 | HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | Actinium Pharmaceuticals, Inc. | LOCKARD, JON MCCLELLAND | 1647 | Non-Final OA | Nov 22, 2021 |
| 17606254 | COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES | Actinium Pharmaceuticals, Inc. | JONES, DAMERON LEVEST | 1618 | Final Rejection | Oct 25, 2021 |
| 17494690 | MODULATING ISCHEMIC INJURY | Noveome Biotherapeutics, Inc. | CLARKE, TRENT R | 1651 | Final Rejection | Oct 05, 2021 |
| 17197580 | Use of ST266 to Treat Severe Systemic Inflammation and Post-Acute COVID-19 Syndrome | Noveome Biotherapeutics, Inc. | FORD, VANESSA L | 1674 | Final Rejection | Mar 10, 2021 |
| 16954105 | COMBINATION IMMUNOTHERAPY AND CHEMOTHERAPY FOR THE TREATMENT OF A HEMATOLOGICAL MALIGNANCY | Actinium Pharmaceuticals, Inc. | WELLS, LAUREN QUINLAN | 1622 | Non-Final OA | Jun 15, 2020 |
| 16755589 | COMBINATION THERAPY FOR TREATMENT OF A HEMATOLOGICAL DISEASE | Actinium Pharmaceuticals, Inc. | BUTTICE, AUDREY L | 1647 | Final Rejection | Apr 12, 2020 |
| 16755590 | ANTI-CD45-BASED LYMPHODEPLETION METHODS AND USES THEREOF IN CONJUNCTION WITH ACT-BASED CANCER THERAPIES | Actinium Pharmaceuticals, Inc. | JOHANSEN, PETER N. | 1644 | Final Rejection | Apr 12, 2020 |
| 16627872 | TREATMENTS FOR A HEMATOLOGICAL MALIGNANCY | Actinium Pharmaceuticals, Inc. | SAMALA, JAGADISHWAR RAO | 1618 | Non-Final OA | Dec 31, 2019 |
| 16690197 | Novel methods for delivering therapeutics agents to the eye via the nasal passages | Noveome Biotherapeutics, Inc. | MOSS, NATALIE M | 1653 | Non-Final OA | Nov 21, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial